HCPCS J0134: Injection, Acetaminophen (Fresenius Kabi), 10 mg
HCPCS Level II code J0134 denotes a 10 mg injection of acetaminophen produced by Fresenius Kabi and identified as not therapeutically equivalent to J0131. This medication-level HCPCS code matters nationally because it distinguishes product-specific billing for parenteral acetaminophen formulations, which affects reimbursement, inventory management, and billing accuracy in hospitals, infusion centers, and emergency departments. Major payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will learn what this code represents clinically and operationally, how it is used across typical sites of service, and where it diverges from other acetaminophen HCPCS codes due to product-specific equivalency notes. The publication also summarizes common payer coverage considerations and the types of benchmarks and policy updates relevant to HCPCS medication coding. Where input data is incomplete, the text notes “Data not available in the input.” The goal is to provide clear, actionable reference material for coding specialists, revenue cycle staff, and policy analysts handling billing for parenteral acetaminophen products.
Sign up for hcpcs J0134 policy alerts
Get alerted when payer policies referencing J0134 are released or updated.
Billing Code Overview
HCPCS Level II code J0134 describes an injection of acetaminophen (Fresenius Kabi), 10 mg, explicitly noted as not therapeutically equivalent to J0131. This code represents billing for a parenteral formulation of acetaminophen supplied by Fresenius Kabi.
Service Type: Injection / Parenteral Medication
Typical Site of Service: Outpatient infusion clinic, hospital inpatient or outpatient setting, emergency department, or other clinical locations where intravenous or intramuscular medications are administered.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult hospitalized for moderate to severe acute pain or postoperative pain where oral acetaminophen is not feasible or absorption is unreliable. The patient may have undergone abdominal surgery, orthopedic joint replacement, or experienced severe nausea/vomiting, and requires intravenous acetaminophen (brand: Fresenius Kabi) dosed per institutional protocol. The clinical workflow: the prescribing clinician documents indication and dose in the medical record; pharmacy verifies allergies, prepares the J0134 product in a sterile environment and labels it for administration; nursing confirms identity and administers the intravenous injection/infusion per facility policy; pain scores and vital signs are monitored post-administration; administration is charted in the medication administration record (MAR) and billing is submitted using HCPCS code J0134 with applicable modifiers reflecting payer, service circumstances, or drug handling (for example, a discarded drug amount or billing exception).
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
JW | Drug amount discarded/not administered | When part of a single-use vial is discarded and payer allows separate reporting of discarded portion |
JZ | Drug not administered to patient (zero drug wasted) | When drug is billed but not administered due to patient condition and documentation supports billing policy |
JG | Professional dispensing fee (Medicare Part B paid under competitive acquisition) | When applicable under payer rules for provider-administered drugs |
QX | CRNA service with medical direction by physician | When a certified registered nurse anesthetist provides services under physician supervision during administration in anesthesia context |
QY | Medical direction of two, three, or four concurrent anesthesia cases | When physician direction meets criteria during anesthesia-associated administration |
25 | Significant, separately identifiable E/M service by the same physician on the day of procedure | When a distinct E/M visit is provided and documented on the same day as drug administration |
59 | Distinct procedural service | When another service on the same day is separate and not bundled with the drug administration |
52 | Reduced services | When drug administration or associated service is partially reduced or not completed as described |
53 | Discontinued procedure | When administration was started but discontinued due to patient status |
78 | Unplanned return to the operating/procedure room by the same physician following initial procedure for a related procedure during the postoperative period | When an unplanned reoperation necessitates additional drug administration |
80 | Assistant at surgery | When an assistant surgeon participates and payer requires modifier for billing relationships |
AS | Physician assistant, nurse practitioner, or clinical nurse specialist when performed in whole or in part by these practitioners | When advanced practice clinicians administer or manage therapy per payer rules |
RT | Right side | When laterality is required by payer or documentation (rare for IV drug but included per common modifier lists) |
LT | Left side | As above for laterality |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
207P00000X | Anesthesiology | Commonly manages perioperative and postoperative IV analgesia |
207L00000X | Pain Medicine | Specialists who administer or direct IV non-opioid analgesics |
207Q00000X | Emergency Medicine | Administers IV acetaminophen for acute pain when oral route is unavailable |
163WP0800X | Pharmacy | Clinical pharmacists prepare and verify parenteral drug products |
208000000X | Internal Medicine | Hospitalists who order and manage inpatient analgesic therapy |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
R52 | Pain, unspecified | Common indication for IV analgesia when specific pain etiology is not yet categorized |
G89.18 | Other acute postprocedural pain | Typical after surgical procedures when IV acetaminophen may be used as part of multimodal analgesia |
K91.89 | Other postprocedural complications and disorders of digestive system | Patients with postoperative nausea/vomiting or impaired GI absorption may receive IV acetaminophen |
S72.001A | Fracture of unspecified part of neck of right femur, initial encounter for closed fracture | Acute orthopedic injury where IV analgesia is used preoperatively or when oral route is contraindicated |
T78.01XA | Anaphylactic reaction due to peanuts, initial encounter | Example of a scenario where IV medications are required and oral medications are not appropriate; careful drug selection required |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
96372 | Therapeutic, prophylactic, or diagnostic injection (specified substance) subcutaneous or intramuscular | May be used for parenteral analgesic administration when IV push is not performed; billed when an injection service is provided concurrently in outpatient settings |
96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | Used when IV acetaminophen is administered as an infusion requiring billing for IV infusion setup and initial time-based service |
96367 | Intravenous infusion, each additional hour (List separately in addition to code for primary infusion) | Used when IV infusion of analgesic extends beyond the initial hour |
96374 | Intravenous push, single or initial substance/drug | Used when the medication is administered by IV push and facility or payer requires coding of the injection service |
99223 | Initial hospital care, typically 70 minutes or more | Documentation of inpatient evaluation and management on the day of administration may be reported with appropriate modifier when a significant, separate E/M is provided |